A novel complex of elfamycin-type antibiotics has been isolated from submerged fermentation of either Streptomyces violaceoniger AB999F-80 or Streptomyces violaceoniger AB 1047T-33. Antibiotics were extracted from the fermentation broth with ethyl acetate and from the mycelia with acetone. Purification of individual components was achieved by a combination of solvent partitions, Sephadex LH-20 exclusion, Ci8 bonded-phase silica gel adsorption, diol partition and liquid-liquid countercurrent chromatographies. Seven closely related components were separated and assigned structures 4, ll, 12, 13, 14, and 16 to phenelfamycins A to F respectively and structure 17 to unphenelfamycin. These structures were elucidated employing a variety of spectroscopic techniques, including extensive use of ID and 2D NMR spectroscopy.
In the course of screening microorganisms for the production of antibiotics with activity against anaerobic bacteria, a Streptomyces species was discovered which produced a novel complex of elfamycin-type antibiotics. Companion papers1'50 describe the taxonomy and fermentation of the producing organism and the biological properties of some of the individual antibiotics produced. This paper will describe the isolation of these antibiotics and the elucidation of their structures.
Results and Discussion

Isolation of Phenelfamycin A and Unphenelfamycin
Eighty liters of submerged fermentation broth of Streptomyces violaceoniger AB 999F-80 prepared as outlined in ref 1 was adjusted to pH 4.0 with H2SO4. Mycelial mass was then removed by centrifugation and filtration and retained. Filtered broth was extracted with EtOAc (3 x 1/3 volumes), the EtOAcextracts were combined and concentrated under vacuum to leave 10 g of dark oil. This material was partitioned between w-hexane and MeOH(10 liters of each). The MeOH layer was concentrated under vacuumto an oil. This oil was applied to a diol-bonded silica gel column pre-equilibrated in the lower phase of toluene -EtOAc-MeOH-H2O (1 : 1 :1 : 1) and eluted with the upper phase of this solvent system. Active fractions from the diol column were pooled and concentrated to an oil. This oil was subjected to countercurrent chromatography on an Ito multilayered coil planet centrifuge (CPC) employing a solvent system of toluene -EtOAc -MeOH-H2O(1 : 1 : 1 : 1) with the upper phase as mobile. This CPC separation yielded pure phenelfamycin A (3.0 mg/liter) and unphenelfamycin (0. 1 5 mg/liter).
The mycelial mass from this same fermentation was extracted with acetone (5 x 1 liter). The combined acetone extracts were concentrated under reduced pressure to an oil which was applied to a Sephadex LH-20 column and eluted with MeOH.Active fractions from the Sephadex LH-20 column were combined, concentrated and applied to a Baker C18 bonded-phase column eluted with a gradient of 0 to 100% CH3CN-MeOH(1 : 1) in water. This yielded pure phenelfamycin A at a level of 3.75 mg/liter of whole broth.
Isolation
of Phenelfamycins B, C, D, E and F The pH of a 5,100-liter fermentation of S. violaceoniger AB999F-80 was adjusted to 4.3 with H2SO4. The whole broth was then passed through a desludging machine (DeLavol PX-207) to remove most of the mycelia. The clarified broth was extracted with EtOAc(3 x 1,500 liters), the EtOAc extracts were combined and concentrated under reduced pressure to leave ca, 4 liters of dark oil. This oil was partitioned between w-hexane and MeOH(60 liters of each). The MeOHlayer was further extracted with w-hexane (2 x 60 liters) then concentrated under reduced pressure to a dark oil. This oil was partitioned between CHC13-MeOH-aqueous 0.1 % H3PO4(20 liters of each). The lower layer of this partition was extracted with aqueous 0.05 m NaHCO3, pH 9.5 (4x 10 liters). Aqueous extracts were combined and concentrated under reduced pressure to leave a dark solid residue. This residue was chromatographed in ten equal portions on a diol-bonded silica gel column pre-equilibrated with the lower layer of CHC13-EtOAc-MeOH-H2O (3 :3 :2:4) and eluted with first the lower, then the upper layer of this solvent system. Active fractions from all ten chromatographies on this column were combined, concentrated and applied to a Baker C18 bonded-phase silica gel column eluted with a CH3CN -0.1 % aqueous HOAc (1 : 1) to CH3CN gradient. Active fractions from this column were combined and concentrated to a tan solid residue. A portion of this residue was applied to a Merck C18 bonded-phase Lobar column and eluted with CH3CN-aqueous 0.1 % H3PO4 (1 : 1) to yield pure phenelfamycins A, B, C, D, E and F. These components elute in the order A, G, E, B, D, F both here or on a Whatmananalytical C18 bonded-phase HPLCcolumn eluted with an aqueous acetonitrile gradient.
The mycelia initially removed by desludging from this large fermentation was soaked in acetone (2x200 liters) to lyse the cells and release antibiotic. The acetone layers were combined and concentrated to a dark viscous oil which was partitioned between «-hexane and MeOH(60 liters of each). The MeOHlayer was further extracted with «-hexane (2 x 60 liters) then concentrated under reduced pressure to leave a dark oil. This oil was partitioned between CHC13-MeOH-aqueous 0.1 %H3PO4 (10 liters of each), the layers were separated and the lower layer was extracted with pH 9.5, 0.1 m bicarbonate buffer (20 liters). The lower layer from the bicarbonate extract was concentrated under reduced pressure to a dark solid. This solid was applied to a diol-bonded silica gel column and eluted with a 0 to 100% MeOHgradient in CH2C12. Active fractions from the diol column were pooled to yield pure unphenelfamycin (~20 mg/liter of whole beer). The bicarbonate layer from the above extract was concentrated under reduced pressure to yield a dark solid residue. This residue was triturated with CHC13 (20 liters) then filtered. CHC13 insoluble material was applied to an Amberlite XAD-2column and eluted with a 1 : 1 water -MeOHto MeOHgradient. Active fractions from the Amberlite XAD-2column were combined and concentrated under reduced pressure to a brown solid.
To the CHC13soluble portion of the above trituration was added 40 liters of^-heptane whereupona flocculant precipitate formed. This precipitate was removed by filtration and combined with active fractions from the Amberlite XAD-2column of the original CHC13insoluble material. This combined material was adsorbed onto a diol-bonded silica gel column and eluted first with the upper then the lower layer of the biphasic solvent system CHC13-EtOAc-MeOH-H2O (3:3:2:4). Two active bands were eluted from this diol column. The first was applied to a Sephadex LH-20column and eluted with CHC13-heptane-EtOH (10: 10: 1) to yield pure phenelfamycins A, B and C. The second was applied to a Baker C18 bonded-phase silica gel column eluted with a CH3CN-0.1 % HOAc (1 : 1) to CH3CNgradient to yield pure phenelfamycin A. Material which was soluble in the CHC13 -heptane soluble (triturated into CHC13and did not precipitate with heptane) was concentrated under reduced pressure to leave a brown oil. This oil was chromatographed in five equal portions on a silica gel column eluted with 2-PrOH -CH2C12(1 : 10). Active fractions from this column were pooled and concentrated under reduced pressure to a tan solid. Portions of this solid were applied to a Merck C18 bonded-phase Lobar column and eluted with CH3CN-aqueous 0.1 % H3PO4 (1 : 1). This column yielded pure phenelfamycins A, B, C, D, E and F.
Isolation of Phenelfamycins E and F from Culture B A second isolate, S. violaceoniger AB 1047T-33, was discovered which also produced the phenelfamycins. HPLCanalysis monitored by diode array UVdetection indicated that this culture was producing phenelfamycins E and F as the major members of the complex. Twenty liters of whole broth from 200 x 500 ml shaken flasks were harvested and phenelfamycins A (0.45 mg/liter), B (1.25 mg/liter), E (17.4 mg/liter), and F (12.25 mg/liter) were isolated as outlined in Fig. 1 .
Structure Determination of Phenelfamycin A The *H NMRspectrum of phenelfamycin A (Fig. 2) aurodox4>5), an antibiotic first discovered in 1973. The term "elfamycins" has been given to this class based upon the memberscommon mode of action, the interference with protein synthesis at the step involving elongation factor Tu (or EF Tu). Most elfamycins of known structure, including efrotomycin6) , heneicomycin7) and kirrothricin8) contain an intact, or partially reduced, 4-hydroxy-a-pyridone moiety which does not appear to be present in the structure of phenelfamycin A. A heteronuclear multiple bond correlation (HMBC)experiment^indicated that a carbonyl carbon at 8 1 67.7 (quaternary (Q)) coupled into the triene 3 as evidenced by connectivity peaks to the olefinic proton at 8 5.92. This evidence, in-addition to the extraction profile indicating the acidic nature of phenelfamycin A, led us to suspect a carboxylic acid triene moiety. Further substantiating this, a recently reported antibiotic, L-681,217lo:>, containing this same fragment served as a good UVspectral model. Having established the class of antibiotics to which phenelfamycin A (4) belongs, we will here present the full structure for ease of presentation of the remaining data. Based upon a heteronuclear correlation map(HETCOR) experiment, proton signals were assigned to their respective carbon atoms. The results are outlined in Tables 1 and 2 . The three partial structures 1, 2 and 3 account for 13 of the 18 down field protons.
The remaining five protons of phenelfamycin A with signals at ca. 3 7.3 were not coupled outside of that region and correlated to three carbon signals (degenerate) at 3 130.2, 129.1 and 127.6 indicative of an unsubstituted phenyl ring. An HMBC experiment indicated that this benzene ring was attached to a methylene with protons at 3 3.71 (2H, s) which was itself connected to an ester carbonyl at 3 171A, hence defining a phenacetate moiety 5.
The three olefinic fragments 1~3 previously described could each be extended via a series of homonuclear and heteronuclear correlation experiments as well as single frequency decoupling. The methyl terminating diene fragment 1 (carbons 26~30 in 4) is coupled to an oxygenated methine with carbon and proton chemical shifts of 3 76.8 (CH) and 4.31 (1H, br d, /=6.0 Hz) respectively. This proton couples only into the olefinic system and hence is adjacent to a quaternary carbon atom. This carbon was identified as that at 3 39. coupled into this quaternary carbon at 3 39.5. These observations fit well the oxygenation pattern commonin elfamycins. In addition, the 3 3.83 proton (23-H) shows a strong nuclear Overhauser enhancement (NOE) to that at 3 4.31 (25-H) indicating a 1,3 diaxial relationship between the two. A coupling constant of 3.7 Hz between the 23-and 22-H's places the latter in an equatorial orientation. The chemical shift of 3 5.02 for 22-H suggests that this carbon carries an acyloxy group and as previously mentioned this hydrogen is coupled to the phenacetate ester carbonyl carbon thus setting the site of attachment for that group as C-22, and defining a partial structure 6. The second diene moiety 2 (carbons 14~17) is connected at C-17 to a methylene with proton and carbon chemical shifts of 3 4.02 (1H, br ddd, /=15.6, 6.4 and 1.5 Hz), 3.88 (1H, br ddd, /=15.2, 6.4 and 1.3 Hz) and 41.7 (CH2) respectively. This is suggestive of an amide methylene thus correlating the fragment of carbons 14~19 in 7 to a similar entity in aurodox.
The triene carboxylic acid group of phenelfamycin Aattaches to the structure at an oxygenbearing methine with carbon (C-8) and proton chemical shifts of 3 75.0 (CH) and 4.37 (1H, m) respectively. A wide diagonal contour for the two proton envelope at~3 4.37~4.38 suggests that these two methine protons -the <5 4.38 correlating to a carbon at 5 84.3 -are coupled to one another. The Decoupling and COSYexperiments also reveal a 2,6-dideoxy sugar moiety (9) present in phenelfamycin A. An anomeric proton at 3 4JO (1H, br s) couples into a methylene signal at 3 1.80 (2H, m) by only two small coupling constants indicating that it must be in an equatorial orientation. The methylene protons then couple into a methine by two distinct coupling constants of /=11.8 and 4.9 Hz. The large coupling constant (ll.8 Hz) between one methylene proton and the signal at 3 3.48 (3'-H) indicates that the 3'-H is axial. This axial 3'-H further couples into a signal at~3 3.70 (4'-H) which is obscured by other protons in the region and hence whose multiplicity cannot be determined. Howeverthe small 3',4' coupling, as observed in the 3'-H splitting pattern, places the 4'-H in an equatorial orientation.
A methyl (C-6') whose protons appear at 3 1.17 (3H, d, J=6.6 Hz) is coupled to a methine (C-5') at 3 3.68 (1H, q, /=6.61 Hz). This 3 3.68 methine experiences a strong NOE to the 3' axial proton at 3 3.48. These observations define the relative stereochemistry of the sugar as shown in 9. A second methoxy group in phenelfamycin A, as yet unplaced, can be assigned on C-3' on the basis of chemical shift. Fragments 6 to 8 and this substituted C-20 moiety can be connected to describe an elfamycin-type antibiotic structure. It remains to determine the point of attachment of the sugar 9. Weoriginally assigned the site of sugar attachment based upon analogy to efrotomycin as being at C-23. Structure 10 was thus presented at the 1987 Intersci. Conf. on Antimicrob. Agents Chemother.10. Data presented at the 1988 International Conference on the Biotechnology of Microbial Products by Lederle authors12), however, led us to re-investigate this assignment. These authors presented structures identical to our phenelfamycins E and F (described later in this paper) except for the site of trisaccharide attachment. 13C NMRspectra run in acetone -H2Oand acetone -D2Owere therefore compared. In this experiment, carbons bearing an OHshould differ somewhat in chemical shift between the two sets of conditions as an ODwill exert different effects upon chemical shift of neighboring carbons than will an OH. In this case, the atoms C-23 and C-33 whose carbon signals appear at 3 72.0 and 64.0 respectively were examined. The 3 64.0 signal appeared at the same chemical shift in each solvent system whereas the 3 72.0 in acetone -H2Oappeared at 3 71.9 in acetone -D2O. This shift was easily observed when spectral addition techniques were employed. Thus C-23 must bear an OHgroup, leaving by default, the site of attachment of 9 at C-33 as in 4. A mass spectrum run in the fast atom bombardment positive ion mode gave a parent peak at m/z 938, consistent with this structure whose molecule formula is C51H71NO15.
Structure Determination of Phenelfamycin B Phenelfamycin B (ll) was isomeric with phenelfamycin A as evidenced by their mass spectra, each indicating a protonated molecular ion of m/z 938. The 13C and 2H NMRspectra of phenelfamycins A and B were quite similar (see Tables 1 and 2 ) with significant differences only in the region of carbon atoms 20~24 and groups attached to that portion of the backbone. In particular, carbons 22 and 23 differ most in shift values (2.6 and 4.5 ppm, respectively) between phenelfamycins A and B, and the axial methyl (C-34) at C-24 shows a smaller difference of 1.5 ppm. The XHNMRspectra of phenelfamycins A and B differ from one another at C-20 by 0.27 ppm and by 0.22 ppm at the attached C-33. Further, the proton chemical shifts of the methyls attached to C-24 differ by 0.06 and 0.22 for the axial and equatorial, respectively. Chemical shifts of the protons of sugar 9 differ at the anomeric and C-4' by 0.12 and 0.23 ppm, respectively. In addition, differences occur in the signals assigned to the phenacetate methylene protons. These protons resonate as a 2H singlet at 3 3.71 in the spectrum of phenelfamycin A, but in that of phenelfamycin B they are resolved with XHNMRsignals of Phenelfamycin D (13) was isomeric with phenelfamycin C with a protonated molecular ion at m/z 1,083* consistent with a molecular formula of C58H83NO18.Only a small quantity of this material was available and hence 13C NMRdata could not be acquired. XHNMRand COSYspectra suggested assignment (see Table 2 ) of a disaccharide structure, bearing the same relationship to phenelfamycin C as phenelfamycin B does to phenelfamycin A. A comparison of XHNMRdata (see Table 3 Tables 1 and 2 define an aglycone portion for phenelfamycin E identical to that of phenelfamycins A and C. The site of attachment of the phenacetyl moiety is set at C-22 as in phenelfamycins A and C based upon an NOE between 25-H at 8 4.33 and an 23-H whose chemical shift of 8 3.81 indicates that this proton is not on a carbon bearing an acyloxy function. The phenacetyl methylene protons in phenelfamycin E appear as a singlet in the XHNMRspectrum (Table 3) . Remaining signals in the *H NMRspectrum of phenelfamycin E could be assigned to three sugar moieties 15a, 15b and 15c. Twoof these sugars, 15a and 15c, were identical to one another and to the sugars present in phenelfamycins A~D. (XHNMRchemical shift assignments are recorded on the structure and multiplicities can be found within , 6-H) . The large coupling constant of the anomeric proton requires that it be axial. Twolarge coupling constants for the 5 1.54 proton at carbon 2 suggests that it is an axial proton with one large (.7=12.3 Hz) geminal coupling and a second axial-axial (9.0 Hz) coupling. The remaining small coupling constant (/=1.8 Hz) requires that the proton of carbon 3 be equatorial. Protons on carbons 4 and 5 are coupled to one another by a coupling constant of /=9.6 Hz indicating that each must be in an axial position. These data thus define a sugar of structure 15b.
The order in which these sugars are attached to the aglycone was determined by 13C NMRand heteronuclear multiple bond correlations with particular reference to the connectivities around C-4 of the three sugars. These carbons have 13C NMRshifts of3 82.7, 74.2 and 67.8 the last of which would be expected to be an alcohol bearing carbon and hence belongs to the terminal sugar. The sugar whose C-4 resonates at 8 67.8 has an anomeric proton at 8 4.95. A heteronuclear multiple bond correlation map reveals that this 8 4.95 proton is coupled to the C-4 at 8 82.7. This carbon is found in the sugar of structure 15b and hence must be the centrally attached of the 3 sugars. Similarly, this central sugar has an anomeric proton at 8 4.80 and this shows a heteronuclear multiple bond correlation to the C-4 at 8 74.2 which appears in the third and therefore inner most sugar.
Phenelfamycin F (16) has a MW1,226 consistent with a molecular formula of C65H95NO21,isomeric to phenelfamycin E. That the aglycone portion of phenelfamycin F is equivalent to that of phenelfamycins A and C was determined by 13C and XHNMRhomo and heteronuclear experiments, the results of which are tabulated in Tables 1 and 2 . The site of attachment for the phenacetyl group is determined to be C-23 based upon an NOEbetween a 25-H signal at 8 4.33 and a 23-H signal at 8 4.96 whose chemical shift indicates that C-23 is an ester bearing carbon. As illustrated in Table 3 , 2H NMRanalogies for protons on carbon atoms 20, 33, 34, 35 and phenacetyl methylene hold between phenelfamycins E and F as between pairs phenelfamycins A, B and C, D. The trisaccharide portion of phenelfamycin F is identical to that of phenelfamycin E as determined by 1H NMRdecoupling and CAMEL techniques. 13C and *H NMRsignals for these sugars are tabulated in Tables 1 and 2. Structure Determination of Unphenelfamycin Unphenelfamycin (17) has a molecular weight of 819 as determined by positive ion FAB-MSof the sodium salt (m/z 842). This is consistent with a molecular formula of C43H65NO14 for unphenelfamycin. Immediately obvious from the XHNMR spectrum of unphenelfamycin was the absence of the 5 proton signal of a phenacetyl moiety observed in the spectra of phenelfamycins A~F at~8 7.3. In addition, the unphenelfamycin *H NMRspectrum lacked an ester methine proton observed at 3 5.0 in the phenelfamycins spectrum and this was replaced by a proton signal at 8 3.59 indicative of a change from an ester to alcohol methine. The 13C and XHNMRdata (see Tables 1 and 2 ) for unphenelfamycin mapped very well, with the exception of the phenacetate ester noted, to that of phenelfamycin A and decoupling of the former led to identical structural assignments.
This spectroscopic analysis defines the phenelfamycins as a novel family of the elfamycin class of antibiotics. The family differs structurally from known members of this class by several interesting features. The lack of a terminal 3-hydroxypyridone moiety has only one previous precedent, namely L-681,21710). At C-20 all previously known elfamycins carry an ethyl group which, in the case of aurodox is butyrate derived143. Phenelfamycins have a substituted hydroxymethyl substituent at this position which is interesting biogenetically. The phenylacetate moiety is uncommonand without precedence in this class of antibiotics. All of the phenelfamycins are glycosides, whereas, the disaccharide, efrotomycin, is the only other known glycosylated elfamycin. The arrangement of sugars in the trisaccharide is particularly interesting in that the trisaccharides differ from the disaccharides by having a different sugar as the central moiety of the trisaccharide chain. This also raises interesting questions of biosynthesis.
Experimental General Procedures
Optical rotations were measured on a Perkin-Elmer Model 241 polarimeter in 10 cm tubes. MP's were determined on a Hoover Unimelt and are reported uncorrected. IR spectra were recorded on a Perkin-Elmer 683 dual beam dispersive instrument and UVspectra on a Perkin-Elmer Lambda3B UV-visible spectrophotometer.
Mass spectra were measured on a Kratos MS-50 spectrometer.
NMRspectra were acquired on either a General Electric GN300or GN500spectrometer with 5 mm probes. 13C and XHNMRspectral data for the phenelfamycins are compiled in Tables 1 and 2 
